Research - Poznań, Greater Poland Voivodeship, Poland
The BioVentures Institute is an innovation-driven molecular biotechnology company, conducting applied research, product development and production, utilizing advanced genetic engineering, molecular biology, biochemical and microbiological technologies. BioVentures Institute developed DNA-FACE™ (DNA Fragment Amplification & Concatemeric Expressed Nucleic Acids and Proteins) technology. DNA-FACE™ is a universal biotechnological platform, created with the use of genetic engineering methods, based on directional, ordered amplification of natural or designed DNA fragments, coding for a specific function. This isothermal enzymatic reaction leads to the construction of targeted, concatemeric biological macromolecules, including DNA, RNA, proteins. DNA-FACE™ is applicable to the development of new generation, protein- or mRNA-based vaccines, genetically programmed DNA, RNA, mRNA, proteins and biological drugs, as well as to industrial and environmental processes.
Gmail
Varnish
Wix
Mobile Friendly
Google Cloud Hosting